Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Koudriavtseva

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Bailliere'S Clinical Neurology|April 2, 1999
Interferon beta 1aC Pozzilli, T Koudriavtseva
AJNR. American Journal of Neuroradiology|January 17, 2015
Brain perfusion and vasoreactivity in multiple sclerosisT Koudriavtseva, E Sbardella, C Mainero
Clinical and Experimental Immunology|January 7, 2014
Long-term follow-up of peripheral lymphocyte subsets in a cohort of multiple sclerosis patients treated with natalizumabT Koudriavtseva, E Sbardella, E Trento, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 25, 2005
Devic's neuromyelitis optica and mitochondrial DNA mutation: a case reportA Ghezzi, S Baldini, M Zaffaroni, et al.
Acta Neurologica Scandinavica|November 1, 1995
Fatigue in MS is associated with specific clinical featuresC Colosimo, E Millefiorini, M G Grasso, et al.
Acta Neurologica Scandinavica|February 4, 1998
No increase of serum autoantibodies during therapy with recombinant human interferon-beta1a in relapsing-remitting multiple sclerosisC Colosimo, C Pozzilli, M Frontoni, et al.
Neuroradiology|May 1, 1996
High-dose contrast-enhanced MRI in multiple sclerosisT Koudriavtseva, C Pozzilli, C Di Biasi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 5, 1998
Determinants of Gd-enhanced MRI response to IFN-beta-1a treatment in relapsing-remitting multiple sclerosisT Koudriavtseva, C Pozzilli, M Fiorelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 1, 1997
MRI measures and their relations with clinical disability in relapsing-remitting and secondary progressive multiple sclerosisE Giugni, C Pozzilli, S Bastianello, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 1, 1995
Human recombinant interferon beta in the treatment of relapsing-remitting multiple sclerosis: preliminary observationsC Fieschi, C Pozzilli, S Bastianello, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Bailliere'S Clinical Neurology|April 2, 1999
Interferon beta 1aC Pozzilli, T Koudriavtseva
AJNR. American Journal of Neuroradiology|January 17, 2015
Brain perfusion and vasoreactivity in multiple sclerosisT Koudriavtseva, E Sbardella, C Mainero
Clinical and Experimental Immunology|January 7, 2014
Long-term follow-up of peripheral lymphocyte subsets in a cohort of multiple sclerosis patients treated with natalizumabT Koudriavtseva, E Sbardella, E Trento, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 25, 2005
Devic's neuromyelitis optica and mitochondrial DNA mutation: a case reportA Ghezzi, S Baldini, M Zaffaroni, et al.
Acta Neurologica Scandinavica|November 1, 1995
Fatigue in MS is associated with specific clinical featuresC Colosimo, E Millefiorini, M G Grasso, et al.
Acta Neurologica Scandinavica|February 4, 1998
No increase of serum autoantibodies during therapy with recombinant human interferon-beta1a in relapsing-remitting multiple sclerosisC Colosimo, C Pozzilli, M Frontoni, et al.
Neuroradiology|May 1, 1996
High-dose contrast-enhanced MRI in multiple sclerosisT Koudriavtseva, C Pozzilli, C Di Biasi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 5, 1998
Determinants of Gd-enhanced MRI response to IFN-beta-1a treatment in relapsing-remitting multiple sclerosisT Koudriavtseva, C Pozzilli, M Fiorelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 1, 1997
MRI measures and their relations with clinical disability in relapsing-remitting and secondary progressive multiple sclerosisE Giugni, C Pozzilli, S Bastianello, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 1, 1995
Human recombinant interferon beta in the treatment of relapsing-remitting multiple sclerosis: preliminary observationsC Fieschi, C Pozzilli, S Bastianello, et al.
Pageof 2